益肾骨康方联合热疗治疗骨转移癌疼痛的临床观察  

Clinical Observation in the Treatment of Pain in Bone Metastatic Cancer with Yishengukang Formula and Thermal Therapy

作　　者：高音[1] 冯利[1] 王芳[1] 勾涛[1] 

机构地区：[1]中国中医科学院望京医院,北京110102

出　　处：《世界中西医结合杂志》2014年第7期750-752,共3页World Journal of Integrated Traditional and Western Medicine

摘　　要：目的观察骨转移癌疼痛患者应用益肾骨康方联合热疗镇痛的临床疗效。方法将40例伴有不同程度骨转移癌疼痛的患者随机分为治疗组和对照组。对照组20例,单纯应用氨酚羟考酮片(泰勒宁)控制骨转移癌疼痛。治疗组20例,在对照组治疗基础上内服益肾骨康方联合骨转移部位局部热疗。治疗2周后对两组患者治疗前后疼痛缓解情况、氨酚羟考酮片(泰勒宁)用药剂量、体力状况进行观察和分析。结果治疗后治疗组疼痛缓解情况明显优于对照组(P<0.05);治疗组氨酚羟考酮片使用量减少率远高于对照组(P<0.05);两组治疗后体力状况评分提高率比较,治疗组高于对照组(P<0.05)。结论益肾骨康方联合局部热疗对骨转移癌疼痛有明显控制作用,可减少强阿片类药物用量,提高体力状况,对提高患者生存质量有重要意义。Objective ToobservetheclinicalefficacyofYishenggukangFormulaandthermalthera-pyinthepatientsofpainofbonemetastaticcancer.Methods Fortycaseswererandomizedintoatreatment group and a control group.In the control group,20 cases were treated with Acetaminiphen Oxycodone Tablets to suppress pain of bone metastatic cancer.In the treatment group,20 cases were treated with Yishenggukang Formula and local thermal therapy beside the medication as the control group.In 2 weeks of treatment,pain relief,drug dose of Acetaminiphen Oxycodone Tablets and physical condition were observed and analyzed in thetwogroups.Results Aftertreatment,inthetreatmentgroup,theresultofpainreliefwasremarkablysu-perior to the control group（P〈0.05）.The reducing rate of the drug dose of Acetaminiphen Oxycodone Tab-lets was quite higher than that in the control group（P〈0.05）.The improvement rate of physical condition in thetreatmentgroupwashigherthanthatinthecontrolgroup（P〈0.05）.Conclusion TheallianceofYish-enggukang Formula and local thermal therapy remarkably suppresses pain of bone metastatic cancer,reduces the dose of strong opioids and improves physical condition.It plays the significant role in the improvement of survival quality of patients.

关 键 词：骨转移癌 疼痛 益肾骨康方 热疗 

分 类 号：R273[医药卫生—中西医结合] R738.1[医药卫生—中医肿瘤科]